Predicting power in short periods out of sample. by Mihály Ormos (697939)

Mst1 knockout skewed macrophage polarization toward a proinflammatory and profibrotic phenotype with concomitant down-regulation of CD36. by Jianyang Li (461703)

Climate complexity in the migratory cycle of <i>Ammodramus bairdii</i> by Alexander Peña-Peniche (5687786)

“…A continuous and alarming decrease of its populations has been observed over the last 50 years, and studying its seasonal distribution and associated climatic niches could help improve strategies for its conservation. …”

Explanatory power of risk measures in long term by diversification. by Mihály Ormos (697939)

Secondary attack rates among 1407 close contacts based on case-patient^a characteristics, their own characteristics, and exposure setting. by Joseph Walker (4341838)

Blockade of IFN<i>γ</i> production rescues the T_reg cell homeostatic defect and alleviates systemic autoimmunity in <i>Foxp3</i>^<i>Cre</i><i>miR-142</i><sup><... by Wei-Le Wang (133402)

PCAIs inhibit NCI-H23 cell line viability. by Matthew D. Gregory (19929096)

“…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”

PCAIs disrupt actin filaments in NCI-H23 cells. by Matthew D. Gregory (19929096)

“…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”

PCAIs suppress 3D NCI-H23 cell invasion. by Matthew D. Gregory (19929096)

“…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”

PCAIs suppress NCI-H23 cancer cell migration. by Matthew D. Gregory (19929096)

“…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”

PCAIs induce apoptosis in NCI-H23 cells. by Matthew D. Gregory (19929096)

“…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”

HCV elicits differential expression of circRNAs. by Tzu-Chun Chen (787255)

Mendelian randomization results with COVID-19. by Alish B. Palmos (5857379)

Schematic diagram of STTFP model. by Guozhu Sui (21672798)

Synthesis of Bicyclic 2′-Deoxynucleosides with α-l-<i>ribo</i>- and β-d-<i>xylo</i>-Configurations and Restricted <i>S</i>- and <i>N</i>-Type Conformations by Khalil I. Shaikh (2028820)

“…Two bicyclic 2′-deoxynucleoside analogues are synthesized in 12 steps each from thymidine. With a six-membered ring fused to the C3′−C4′ bond and an α-l-<i>ribo</i>- and a β-d-<i>xylo</i>-configuration, these are conformationally restricted in an <i>S</i>- and an <i>N</i>-type conformation, respectively. …”

Synthesis of Bicyclic 2′-Deoxynucleosides with α-l-<i>ribo</i>- and β-d-<i>xylo</i>-Configurations and Restricted <i>S</i>- and <i>N</i>-Type Conformations by Khalil I. Shaikh (2028820)

“…Two bicyclic 2′-deoxynucleoside analogues are synthesized in 12 steps each from thymidine. With a six-membered ring fused to the C3′−C4′ bond and an α-l-<i>ribo</i>- and a β-d-<i>xylo</i>-configuration, these are conformationally restricted in an <i>S</i>- and an <i>N</i>-type conformation, respectively. …”

Synthesis of Bicyclic 2′-Deoxynucleosides with α-l-<i>ribo</i>- and β-d-<i>xylo</i>-Configurations and Restricted <i>S</i>- and <i>N</i>-Type Conformations by Khalil I. Shaikh (2028820)

“…Two bicyclic 2′-deoxynucleoside analogues are synthesized in 12 steps each from thymidine. With a six-membered ring fused to the C3′−C4′ bond and an α-l-<i>ribo</i>- and a β-d-<i>xylo</i>-configuration, these are conformationally restricted in an <i>S</i>- and an <i>N</i>-type conformation, respectively. …”

Synthesis of Bicyclic 2′-Deoxynucleosides with α-l-<i>ribo</i>- and β-d-<i>xylo</i>-Configurations and Restricted <i>S</i>- and <i>N</i>-Type Conformations by Khalil I. Shaikh (2028820)

“…Two bicyclic 2′-deoxynucleoside analogues are synthesized in 12 steps each from thymidine. With a six-membered ring fused to the C3′−C4′ bond and an α-l-<i>ribo</i>- and a β-d-<i>xylo</i>-configuration, these are conformationally restricted in an <i>S</i>- and an <i>N</i>-type conformation, respectively. …”

Expression of CRYAB in normal and tumor tissue samples across different cancer types. by Rasool Saghaleyni (10526301)

Characterization of vascular morphological properties and comparison of EC monocultures and EC-pericyte co-cultures. by Jaerim Kim (774458)